Clinical Trials Logo

Filter by:
NCT ID: NCT04871074 Active, not recruiting - Alzheimer Disease Clinical Trials

The Synapse Project

Start date: November 18, 2018
Phase: Phase 2
Study type: Interventional

The overarching goal of this project is to use [C-11]UCB-J to obtain spatial information on neuronal synapse abundance and inform Alzheimer's disease (AD) progression. The investigators propose to collect longitudinal amyloid, tau, and Synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) in participants in the Wisconsin Alzheimer's Disease Research Center (ADRC) and Wisconsin Registry for Alzheimer's Prevention (WRAP) across the clinical stages of AD, including cognitively unimpaired biomarker negative, unimpaired biomarker positive, mild cognitive impairment (MCI), and dementia due to AD.

NCT ID: NCT04870970 Active, not recruiting - Smoking Clinical Trials

The Effect of Tobacco Products on Wound Healing

Start date: May 18, 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate the effect of various tobacco products (including but not limited to combustible cigarettes, medicinal nicotine, electronic cigarettes, and smokeless tobacco) on cutaneous wound healing. There will also be a non- smoking control group. This study will be designed as a pilot study. The majority of individuals will be recruited from ongoing studies at the University of Minnesota - Tobacco Research Programs.

NCT ID: NCT04869761 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Stem Cell Therapy for Chronic Kidney Disease

Start date: October 7, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of allogeneic mesenchymal stem / stromal cell therapy in individuals with chronic kidney disease.

NCT ID: NCT04869020 Active, not recruiting - Vertigo Clinical Trials

Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting

Start date: May 7, 2021
Phase: N/A
Study type: Interventional

This study seeks to gather data on the effect of a device, the OtoBand, in participants who have reported symptoms of vertigo, compared to the effect of using one of two sham devices. The study is designed to be conducted remotely using video conferencing between representatives of the manufacturer of the Otoband and participants. In order to comply with requirements for non-essential contact due to the Covid-19 pandemic there will be no person to person contact in the study.

NCT ID: NCT04868903 Active, not recruiting - Clinical trials for SARS-CoV-2 Infection

Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19

Start date: November 30, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the risks of COVID-19 in individuals from Chicagoland communities randomized to low (400 IU/day) vs. moderate (4,000 IU/day) or high (10,000 IU/day) dose vitamin D.

NCT ID: NCT04868773 Active, not recruiting - Colorectal Cancer Clinical Trials

Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

Start date: July 16, 2021
Phase: Phase 1
Study type: Interventional

This is a phase I clinical trial assessing the safety and recommended phase II dose of cabozantinib in combination with trifluridine/tipiracil (TAS102) in patients with metastatic colorectal carcinoma (mCRC).

NCT ID: NCT04868656 Active, not recruiting - Early Ambulation Clinical Trials

Implementing a Hospital-Based Walking Program (STRIDE): Function QUERI 2.0

STRIDE
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Implementing a Hospital-Based Walking Program (STRIDE): Function QUERI 2.0 aims to compare implementation strategies for large-scale spread of STRIDE, a supervised walking program for hospitalized older Veterans. The overall goal is to implement, evaluate, and sustain STRIDE in 32 additional VA hospitals using a type III effectiveness-implementation hybrid design framework.

NCT ID: NCT04868539 Active, not recruiting - Sleep Clinical Trials

Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This project is designed to test for the first time whether glucose metabolism is differentially impaired by sleep restriction with and without additional exposure to artificial light at night (ALAN).

NCT ID: NCT04868110 Active, not recruiting - Clinical trials for Gestational Weight Gain

Preventing Excessive Weight Gain and Maternal and Infant Fat Accretion

SPROUT
Start date: June 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to learn if consuming a high fiber diet will reduce gestational weight gain and maternal and infant fat accretion.

NCT ID: NCT04867707 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

NAED
Start date: July 14, 2021
Phase: Phase 2
Study type: Interventional

The objective is to determine if neuraminidase inhibition with zanamivir is efficacious as a therapeutic strategy to restore endothelial function in T2D patients.